Perhaps you want to state exactly what assertion made on the "wordpress" website you find to be factually inaccurate? Are you trying to say that PT wasn't involved in Biosign, or perhaps, contrary to the article, that Biosign provided good returns to most investors? Please enlighten us by explaining precisely how you distinguish Biosign from a pump-and-dump? You might also want to explain what PT brought to the table other than his stock promotion effort. I pretty sure he doesn't have an M.D. and isn't a medical researcher.
While you're at it, explain why Opus sold the Sphere 3D paper, and specifically, why the impending default wasn't cured and why the paper went to a firm in the role that Colbeck generally plays. Explain why yet another two week extension of the default declaration was required. Also explain how, exactly, if there were a credible offer of $50MM on the table, why did the terms under Amendment Number Ten of the Credit Agreement not met? It is very obvious that Opus didn't believe there was a credible offer on the table, and they have some serious skin in the game.
For what it's worth, I understand why Colbeck would grant an extension. I'm sure their discount was several million, and I'd give it two weeks to turn that kind of profit if I had bought that note. I wouldn't give it a lot more though, because as cash is burned, the value of the "morsels" decline. You can figure it costs Colbeck at least $1MM a month to sit on the saleable assets, given the current burn.
According to MarketWatch, on 3/2/2014, what is now a current share worth US$0.470295 was then worth US$918.75. Go look it up.
The ANY stock chart looks a whole lot like the Biosign stock chart did. Like ANY, Biosign also had a lot of big, business-saving deals they promoted up to the end.
Offers that weren't taken have the same value as moonbeams. Could'a, should'a, would'a . . . ("subject to conditions") . . .
The Biosign episode is absolutely independently verifiable. The deal with Colbeck is documented in a filing through Sedar, under "News Release - English", filed June 19, 2018 at 16:25:50 ET.
I'm guessing you won't detail your sources, but if you can, please do.
